Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 59 results found. Search for [ Novartis AG ]

Results 1 to 21 of 59
PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

September 24, 2020
The U.S. Department of Justice said on Wednesday the settlement resolves allegations that Gilead improperly used the Caring Voice Coalition as a conduit to cover thousands of patients' co-payment obligations

September 11, 2020
Share market live: Top Sensex losers are IndusInd Bank, PowerGrid and Asian Paints falling over 1%

July 2, 2020
Acting U.S. Attorney Audrey Strauss in Manhattan called the incentives for doctors \"nothing more than bribes,\" and said federal healthcare programs paid hundreds of millions of dollars in reimbursements for prescriptions tainted by kickbacks

New Delhi, June 19, 2020
Novartis' board approved appointment of Sanker Parameswaran as an additional director (Independent and Non-Executive) of the company, to hold office for a period of 5 consecutive years with effect from June 22, 2020

March 21, 2020
In Washington, U.S. President Donald Trump said during a news conference on Friday he is optimistic about the malaria treatment's use against COVID-19

Joe C Mathew | PB Jayakumar
March 4, 2020
'Right now, the focus is  about 80% innovative medicines and 20 per cent generics. We have 15 launches coming up in innovative medicines,' Novartis International CEO said

Joe C Mathew and PB Jayakumar
March 3, 2020
Novartis has completed strategic transactions worth over $70 billion since he took charge as CEO in 2018. In an exclusive interview with Business Today's Joe C. Mathew and P.B. Jayakumar, the second generation Indian American speaks about his vision for Novartis, new launches in India and the growing role of its Hyderabad centre

Joe C Mathew and PB Jayakumar
New Delhi, February 17, 2020
In an interview with Business Today, Narasimhan said expanding our knowledge base about such disease outbreak is important in order to take effective actions to address them

New Delhi, February 14, 2020
Generic drugmakers say they currently have enough active pharmaceutical ingredients supplies from China to cover their operations for up to about three months

New Delhi, September 27, 2019
The move comes after the USFDA asked the company to test the drug for indications of N-nitrosodimethylamine (NDMA) impurity, which the regulator says is a 'probable human carcinogen'

June 24, 2019

New Delhi, June 15, 2019
Currently, Murdeshwar is Novartis' country president in India and is responsible for the company's pharmaceuticals business

December 2, 2018

New Delhi, September 6, 2018
The 131-year-old Sandoz unit was hurt by price pressure in the United States, prompting Novartis Chief Executive Officer Vas Narasimhan to sell the Sandoz unit.
New Delhi, March 29, 2018
ICICI Bank board expresses faith in MD and CEO Chanda KochharICICI Bank board has come out in support of its Managing Director and CEO Chanda Kochhar, saying it has full faith and confidence in her and described certain reports against her regarding credit disbursement to Videocon group as \"malicious and unfounded rumours\". ICICI Bank board also reviewed the bank's internal processes for credit approval and found them robust, the private sector lender said in a statement, as r...

New Delhi, March 28, 2018
Yesterday, Britain's biggest drugs company GlaxoSmithKline (GSK) announced that it will buy the 36.5 per cent stake that Novartis AG owns in their Consumer Healthcare Joint Venture for $13 billion.

Nevin John
July 30, 2016
The critical enablers that Mistry found out are: build competent leadership and committed workforce and promote pioneering as Jamsetji Tata built first integrated steel mill, JRD the first airline and Ratan Tata the first Indian passenger car, Tata Indica.

May 19, 2016
Indian officials say they have proposed an oil-for-drugs barter plan with cash-strapped Venezuela to recoup millions of dollars in payments owed to some of India's largest pharmaceutical companies.

Chennai, March 30, 2016
In a statement issued late Tuesday, the company said a wholly owned subsidiary of Sun Pharma will acquire the portfolio consisting of 14 established prescription brands from Novartis for a cash consideration of $293 million.

PAGES 1 OF 3  123